Results 11 to 20 of about 1,727,469 (168)

Endgame Polio: Role of Novel Oral Polio Vaccine Type 2 [PDF]

Pediatric Infectious Disease, 2022
Polio eradication efforts have seen major advances since 1988 when the thrust for eradication was initiated on a global level. The endgame polio strategy, as announced by the World Health Organization (WHO), is a program from 2019 to 2023 that attempts ...
Sumitha Nayak
doaj   +3 more sources

Assessing the stability of polio eradication after the withdrawal of oral polio vaccine. [PDF]

PLoS Biology, 2018
The oral polio vaccine (OPV) contains live-attenuated polioviruses that induce immunity by causing low virulence infections in vaccine recipients and their close contacts. Widespread immunization with OPV has reduced the annual global burden of paralytic
Michael Famulare, Christian Selinger, Kevin A McCarthy, Philip A Eckhoff, Guillaume Chabot-Couture   +4 more
doaj   +2 more sources

Viral Aetiology of Acute Flaccid Paralysis Surveillance Cases, before and after Vaccine Policy Change from Oral Polio Vaccine to Inactivated Polio Vaccine [PDF]

Journal of Tropical Medicine, 2014
Since 1992, surveillance for acute flaccid paralysis (AFP) cases was introduced in Malaysia along with the establishment of the National Poliovirus Laboratory at the Institute for Medical Research.
T. S. Saraswathy Subramaniam, Mohd Apandi Apandi, Rohani Jahis, Mohd Samsul Samsudin, Zainah Saat   +4 more
doaj   +2 more sources

Oral polio vaccine stockpile modeling: insights from recent experience

Expert Review of Vaccines, 2023
Background Achieving polio eradication requires ensuring the delivery of sufficient supplies of the right vaccines to the right places at the right times.
Kimberly M. Thompson, Dominika A. Kalkowska, Kamran Badizadegan   +2 more
doaj   +2 more sources

Safety and Immunogenicity of Trivalent Oral Polio Vaccine in Vaccinated Children and Vaccine-Naïve Infants: A Phase 4 Study. [PDF]

Vaccines (Basel)
In the context of polio eradication, novel oral polio vaccines for type 2 (nOPV2) were developed, and types 1 and 3 polioviruses are being developed.
Mejía LR, Mendez LP, Rüttimann RW, Gast C, Bandyopadhyay AS.   +4 more
europepmc   +2 more sources

Protecting investments in polio eradication: the past, present and future of surveillance for acute flaccid paralysis. [PDF]

, 2004
In September 2003 a WHO consultation group on vaccine-derived polioviruses (VDPV) concluded that in order to prevent future generations of paralytic polio after interruption of transmission of wild poliovirus, the use of trivalent oral polio vaccine (OPV)
D. L. HEYMANN, E. M. DE GOURVILLE, Heymann, DL, R. B. AYLWARD, Aylward, RB, De Gourville, EM   +5 more
core   +1 more source

Sociocultural determinants of anticipated oral cholera vaccine acceptance in three African settings : a meta-analytic approach [PDF]

, 2016
Controlling cholera remains a significant challenge in Sub-Saharan Africa. In areas where access to safe water and sanitation are limited, oral cholera vaccine (OCV) can save lives. Establishment of a global stockpile for OCV reflects increasing priority
Merten, Sonja, Schaetti, Christian, Sundaram, Neisha, Claire-Lise Chaignat, Mitchell G. Weiss, Hutubessy, Raymond, Weiss, Mitchell G., Sonja Merten, Christian Schindler, Chaignat, Claire-Lise, Said M. Ali, Erick O. Nyambedha, Neisha Sundaram, Schindler, Christian, Raymond Hutubessy, Ali, Said M., Lapika, Bruno, Christian Schaetti, Bruno Lapika, Nyambedha, Erick O.   +19 more
core   +1 more source

Oral cholera vaccine use in Zanzibar: socioeconomic and behavioural features affecting demand and acceptance [PDF]

, 2009
BACKGROUND: Cholera remains a serious public health problem in low-income countries despite efforts in the past to promote oral rehydration therapy as major treatment.
Khatib Ahmed M, Al Pach, Khatib, Ahmed M, Claire-Lise Chaignat, Schaetti, C., Ali Said M, Weiss, M. G., Hutubessy, Raymond, Weiss, Mitchell G, Khatib, A. M., Mitchell G Weiss, Hutubessy Raymond, Schaetti Christian, Ahmed M Khatib, Ali, S. M., Schaetti, Christian, Chaignat Claire-Lise, Ali, Said M, Pach, Al, Pach Al, Pach, A., Chaignat, Claire-Lise, Hutubessy, R., Chaignat, C. L., Raymond Hutubessy, Weiss Mitchell G, Christian Schaetti, Said M Ali   +27 more
core   +2 more sources

Improving community coverage of oral cholera mass vaccination campaigns: lessons learned in Zanzibar [PDF]

, 2012
BACKGROUND: Recent research in two cholera-endemic communities of Zanzibar has shown that a majority (?94%) of the adult population was willing to receive free oral cholera vaccines (OCVs). Since OCV uptake in the 2009 campaign reached only ?50% in these
Claire-Lise Chaignat, Weiss Mitchell G., Schaetti, C., Weiss, M. G., Khatib, A. M., Ahmed M. Khatib (130136), Said M. Ali, Mitchell G Weiss, Hutubessy Raymond, Schaetti Christian, Ahmed M Khatib, Claire-Lise Chaignat (127845), Raymond Hutubessy (130149), Ali, S. M., Khatib Ahmed M., Mitchell G. Weiss, Mitchell G. Weiss (130129), Ahmed M. Khatib, Chaignat Claire-Lise, Ali Said M., Hutubessy, R., Christian Schaetti (130127), Chaignat, C. L., Raymond Hutubessy, Christian Schaetti, Said M Ali, Said M. Ali (130132)   +26 more
core   +1 more source

Circulating vaccine-derived poliovirus: a menace to the end game of polio eradication

Globalization and Health, 2020
The World Health Organisation Western Pacific Region countries were declared free of polio in 2000 until a polio outbreak involving 305 cases occurred in Indonesia in 2006.
Long Chiau Ming, Zahid Hussain, Siang Fei Yeoh, David Koh, Kah Seng Lee   +4 more
doaj   +1 more source